Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Desloratadine Production Not Anticipated In Loratadine Patent – Schering

This article was originally published in The Tan Sheet

Executive Summary

A compound does not need to be explicitly described in writing to be inherently anticipated by a patent, a Federal Circuit judge told Schering-Plough April 8

You may also be interested in...



Generic Claritin Does Not Infringe Schering Patent - Appeals Court

The Aug. 1 decision by a Washington D.C. federal appeals court finding certain loratadine patent claims invalid "does not preclude patent protection for metabolites of known drugs," the judges write

Generic Claritin Does Not Infringe Schering Patent - Appeals Court

The Aug. 1 decision by a Washington D.C. federal appeals court finding certain loratadine patent claims invalid "does not preclude patent protection for metabolites of known drugs," the judges write

Generic Claritin Does Not Infringe Schering Patent - Appeals Court

The Aug. 1 decision by a Washington D.C. federal appeals court finding certain loratadine patent claims invalid "does not preclude patent protection for metabolites of known drugs," the judges write

Topics

UsernamePublicRestriction

Register

PS095337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel